Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beyond Air, Inc.

0.2686
+0.01807.18%
Post-market: 0.2614-0.0072-2.68%19:37 EDT
Volume:1.44M
Turnover:366.12K
Market Cap:23.71M
PE:-0.28
High:0.2709
Open:0.2490
Low:0.2400
Close:0.2506
Loading ...

Beyond Air Gets 180-Day Extension to Regain Nasdaq Compliance

MT Newswires Live
·
05 Feb

Beyond Air granted 180-day extension to regain Nasdaq compliance

TIPRANKS
·
05 Feb

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Requirement

THOMSON REUTERS
·
05 Feb

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

GlobeNewswire
·
05 Feb

BRIEF-Beyond Air Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing

Reuters
·
01 Feb

Beyond Air files $200M mixed securities shelf

TIPRANKS
·
01 Feb

Beyond Air Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $1

THOMSON REUTERS
·
31 Jan

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

GlobeNewswire
·
28 Jan

Beyond Air’s LungFit PH receives market authorization in Australia

TIPRANKS
·
24 Jan

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

GlobeNewswire
·
24 Jan

Beyond Air Up 15%, Insiders Still Down After US$1.60m Purchase

Simply Wall St.
·
20 Jan

Insider Stock Buying Reaches US$1.60m On Beyond Air

Simply Wall St.
·
12 Jan

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GlobeNewswire
·
06 Jan

ADVISORY-Ignore incorrect advisory alert on Beyond Cancer coding error

Reuters
·
04 Dec 2024

Beyond Cancer: Israeli Ministry of Health Approved Use of Low Volume Uno in Phase 1B Clinical Trial of Lv Uno in Combination With Anti-Pd-1 Therapy

THOMSON REUTERS
·
04 Dec 2024

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1B Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (Lv Uno) in Combination With Anti-Pd-1 Therapy

THOMSON REUTERS
·
04 Dec 2024